title: Reutilization of insulin receptor and hormonal response in cultured foetal hepatocytes: the effects of chloroquine and vinblastine.
abstract: The effects of chloroquine and vinblastine (10-100 microM) on insulin degradation and biological action were studied in cultured foetal rat hepatocytes. Insulin degradation, as measured by the release of trichloroacetic acid-soluble radioactivity from 125I-insulin into the medium, was strictly cell-associated, saturable with respect to insulin concentrations and linearly related to the amount of cell-associated hormone. The maximal rate of insulin degradation was 4,700 molecules/min per cell, and its KM about 5 nM. Thus, insulin receptors (30,000 sites/cell; half-life close to 13 hr) must be reutilized 450-fold before being degraded with an average time of reutilization inferior to 10 min. In the presence of 70 microM chloroquine or 100 microM vinblastine, insulin degradation was inhibited by 80% and the amount of cell-associated hormone enhanced 2-3-fold. Nearly total inhibition of insulin-stimulated glycogenesis was obtained with 70 microM chloroquine and 45 microM vinblastine. When hepatocytes were preincubated with chloroquine or vinblastine, insulin binding remained high for up to 4 hr, then progressively decreased thereafter. The addition of 10 nM native insulin during preincubation with the drugs resulted in an earlier and more pronounced decrease in insulin binding, whereas native insulin alone did not induce any change. Both the inhibition of insulin degradation and onset of receptor down-regulation suggest a drug-induced impairment in the receptor reutilization. This defect is correlated to a loss of the glycogenic effect of insulin in cultured foetal rat hepatocytes.
authors.forename: E
authors.initials: E
authors.lastname: Pringault
authors.forename: C
authors.initials: C
authors.lastname: Plas
authors.forename: B
authors.initials: B
authors.lastname: Desbuquois
authors.forename: H
authors.initials: H
authors.lastname: Clauser
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D002738:Chloroquine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004705:Endocytosis / Q000187:drug effects*; D005260:Female; D005947:Glucose / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism*; D007700:Kinetics; D008099:Liver / Q000166:cytology* / Q000196:embryology; D008112:Liver Glycogen / Q000378:metabolism; D011247:Pregnancy; D051381:Rats; D011919:Rats, Inbred Strains; D011972:Receptor, Insulin / Q000378:metabolism*; D014747:Vinblastine / Q000494:pharmacology*
chemical_list: D007328:Insulin; D008112:Liver Glycogen; D014747:Vinblastine; D002738:Chloroquine; D011972:Receptor, Insulin; D005947:Glucose